Illumina Inc
Change company Symbol lookup
Select an option...
ILMN Illumina Inc
AATV Adaptive Ad Systems Inc
MSGS Madison Square Garden Sports Corp
BST BlackRock Science and Technology Trust
ETSY ETSY Inc
SPCE Virgin Galactic Holdings Inc
XNXNX Nuveen New York Select Tax Free Income Portfolio
$NQUSM55102010EURT Nasdaq US Mid Cap Iron and Steel Tot
WPC WP Carey Inc
SCTL Societal CDMO Inc
Go

Health Care : Life Sciences Tools & Services | Large Cap Growth
Company profile

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Closing Price
$240.75
Day's Change
0.94 (0.39%)
Bid
--
Ask
--
B/A Size
--
Day's High
244.69
Day's Low
235.04
Volume
(Light)
Volume:
1,106,105

10-day average volume:
1,759,133
1,106,105

Latest Earnings (Q1 ending 03/2022)

Q1
$1.07
Q1 Consensus estimate
$0.90

Latest Earnings Estimate Range

Highest
estimate
$0.98
Mean
estimate
$0.90
Lowest
estimate
$0.75

Quarterly Consensus Estimates and Ranges

ILMN's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.